Nektar Therapeutics (NKTR)

06:31 AM

Nektar Therapeutics is trying to stage a comeback. But a big test awaits - statnews.com

06:31 AM

Feb 02, 2026

Nektar Therapeutics (NKTR): A Bull Case Theory - Insider Monkey

Feb 02, 2026

Jan 31, 2026

BTIG Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $118 - 富途牛牛

Jan 31, 2026

Jan 30, 2026

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire

Jan 30, 2026

Jan 30, 2026

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NKTR Stock News - Longbridge

Jan 30, 2026

Jan 29, 2026

Where Nektar Therapeutics Stands With Analysts - Benzinga

Jan 29, 2026

Jan 29, 2026

Nektar Therapeutics (NASDAQ:NKTR) Earns "Buy" Rating from BTIG Research - MarketBeat

Jan 29, 2026

Jan 27, 2026

NEKTAR THERAPEUTICS Enters Quiet Period for REZOLVE-AD Study - TradingView

Jan 27, 2026

Jan 26, 2026

Nektar Therapeutics Q3 Loss Narrower Than Expected, Revenues Rise Y/Y - MSN

Jan 26, 2026

Jan 26, 2026

Piper Sandler reiterates Overweight rating on Nektar Therapeutics stock By Investing.com - Investing.com Nigeria

Jan 26, 2026

Jan 26, 2026

Piper Sandler Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $105 - 富途牛牛

Jan 26, 2026

Jan 26, 2026

Nektar Therapeutics (NKTR) Scheduled for January 28 Meeting - GuruFocus

Jan 26, 2026

Jan 26, 2026

Piper Sandler reiterates Overweight rating on Nektar Therapeutics stock - Investing.com

Jan 26, 2026

Jan 26, 2026

Piper Sandler on Nektar Therapeutics (NKTR): 'We See a Substantial Opportunity Into These De-Risked Data' - StreetInsider

Jan 26, 2026

Jan 24, 2026

Nektar Therapeutics (NASDAQ:NKTR) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Jan 24, 2026

Jan 24, 2026

Nektar Therapeutics’ chief R&D officer sells $137,935 in stock By Investing.com - Investing.com India

Jan 24, 2026

Jan 23, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar TherapeuticsNKTR - yourwyominglink.com

Jan 23, 2026

Jan 23, 2026

Nektar Therapeutics (NASDAQ:NKTR) Trading 7% HigherHere's Why - MarketBeat

Jan 23, 2026

Jan 23, 2026

Emerald Mutual Fund Advisers Trust Invests $13.27 Million in Nektar Therapeutics $NKTR - MarketBeat

Jan 23, 2026

Jan 22, 2026

Insider Sell: Jonathan Zalevsky Sells Shares of Nektar Therapeutics - GuruFocus

Jan 22, 2026

Jan 22, 2026

Nektar Therapeutics (NASDAQ:NKTR) Insider Sells $137,935.89 in Stock - MarketBeat

Jan 22, 2026

Jan 22, 2026

Nektar Therapeutics’ chief R&D officer sells $137,935 in stock - Investing.com

Jan 22, 2026

Jan 22, 2026

Emerald Advisers LLC Takes Position in Nektar Therapeutics $NKTR - MarketBeat

Jan 22, 2026

Jan 22, 2026

NK Cell Therapy Market 2034: 7MM Outlook, 30+ Active Developers, IND/NDA Momentum, and Next-Gen CAR-NK Innovations Driving Immunotherapy Advances | DelveInsight - Barchart.com

Jan 22, 2026

Jan 21, 2026

What Recent Price Target Signals For The Evolving Nektar Therapeutics (NKTR) Story - Yahoo Finance

Jan 21, 2026

Jan 20, 2026

Nektar Therapeutics: Share Price Dislocation Masks Rezpeg’s Underappreciated Atopic Dermatitis and Alopecia Areata Upside - TipRanks

Jan 20, 2026

Jan 20, 2026

Corvus pill shows promise in early-stage eczema trial - statnews.com

Jan 20, 2026

Jan 19, 2026

Bond Watch: Should I buy Nektar Therapeutics stock nowJuly 2025 Technicals & Daily Profit Maximizing Trade Tips - baoquankhu1.vn

Jan 19, 2026

Jan 18, 2026

Aug Fed Impact: Should I buy Nektar Therapeutics stock nowMarket Performance Report & Free Community Consensus Stock Picks - baoquankhu1.vn

Jan 18, 2026

Jan 18, 2026

Nektar Therapeutics Stock Defies Short Sellers with Sharp Rally - AD HOC NEWS

Jan 18, 2026

Jan 17, 2026

Nektar Therapeutics’ Earnings Call Highlights Robust Growth and Innovation - MSN

Jan 17, 2026

Jan 16, 2026

Short Interest in Nektar Therapeutics (NASDAQ:NKTR) Rises By 52.3% - MarketBeat

Jan 16, 2026

Jan 16, 2026

Nektar Therapeutics (NASDAQ:NKTR) Trading Up 6.9%Still a Buy? - MarketBeat

Jan 16, 2026

Jan 13, 2026

Nektar Therapeutics (NASDAQ:NKTR) Stock Price Down 6.7%What's Next? - MarketBeat

Jan 13, 2026

Jan 12, 2026

History Review: Is Nektar Therapeutics stock a value trapTrade Entry Summary & Reliable Entry Point Trade Alerts - baoquankhu1.vn

Jan 12, 2026

Jan 11, 2026

Why the JP Morgan conference is important — but not make-or-break - statnews.com

Jan 11, 2026

Jan 10, 2026

BTIG maintains Nektar Therapeutics (NKTR) buy recommendation - MSN

Jan 10, 2026

Jan 10, 2026

Ignore Nektar Therapeutics stock in 2026 and load up on this one instead - MSN

Jan 10, 2026

Jan 10, 2026

Will Nektar Therapeutics (ITH0) stock outperform energy sector in 2025Trade Performance Summary & Step-by-Step Trade Execution Guides - ulpravda.ru

Jan 10, 2026

Jan 10, 2026

Nektar Therapeutics (NKTR) price target increased by 14.31% to 109.43 - MSN

Jan 10, 2026

Jan 09, 2026

Q1 EPS Estimate for Nektar Therapeutics Raised by Analyst - MarketBeat

Jan 09, 2026

Jan 09, 2026

Nektar Therapeutics (NASDAQ:NKTR) Shares Pass Above 200 Day Moving AverageHere's What Happened - MarketBeat

Jan 09, 2026

Jan 09, 2026

Here's why Nektar Therapeutics (NKTR) is a great momentum stock to buy - MSN

Jan 09, 2026